BofA/Merrill Lynch downgraded Nu Skin Enterprises (NYSE: NUS) from Neutral to Underperform with a price target of $63.00 (from $96.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE